Navigation Links
Shanghai ChemPartner's Animal Facility Awarded AAALAC Accreditation
Date:3/1/2010

SHANGHAI, March 1 /PRNewswire-Asia/ -- Shanghai ChemPartner, a leading China-based contract research organization and a wholly-owned subsidiary of ShangPharma, today announced that its animal facility has received accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

AAALAC International is a private, non-profit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. As a result of an extensive on-site evaluation, AAALAC determined that Shanghai ChemPartner's animal facility is committed to the highest level of animal care and research practices.

AAALAC noted the following in its official approval letter: "The Shanghai ChemPartner management and staff are commended for providing sound facilities and programs for the care and use of laboratory animals. Especially noteworthy were the strong administrative commitment to the program, as evidenced by the financial support for the three well maintained, state-of-the-art animal facilities and equipment, as well as the highly capable and qualified animal resources staff; the active, conscientious, capable and very knowledgeable Institutional Animal Care and Use Committee (IACUC); the knowledgeable and experienced animal care and use staff; the dedication of a team who worked extremely well together to ensure responsible and appropriate animal care and use; the excellent documentation (Standard Operating Procedures and guidelines) and records, with attention to detail and completeness; and the good animal health. Therefore, FULL ACCREDITATION is awarded."

"The AAALAC accreditation comes as a result of our efforts in expanding service capabilities from chemistry to preclinical drug development including in vivo pharmacology, drug metabolism and pharmacokinetics (DMPK) and toxicology," commented Michael Hui, founder and CEO of ChemPartner. "We are pleased to receive such high praise from the leading independent world body on the care and use of laboratory animals. We are confident of being an industry leader with the endorsement of AAALAC."

About Shanghai ChemPartner

Founded in 2003, Shanghai ChemPartner (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicology, process R&D, analytical development, formulation and contract manufacturing services to over 120 pharmaceutical and biotech companies in the world. ChemPartner currently has a team of over 1,000 scientists including more than 100 senior scientific leaders with extensive industry experiences gained from leading global pharmaceutical and biotech companies. Headquartered in China, ChemPartner has overseas business development operations in Boston, USA and Copenhagen, Denmark.

About ShangPharma

ShangPharma is a leading China-based outsourcing partner in pharmaceutical and biotechnology research and development, who provides customized services to international pharmaceutical, biotech, agrochemical and chemical companies. As the holding company of Shanghai ChemPartner Co., Ltd., Shanghai ChemExplorer Company Ltd., China Gateway Pharmaceutical (Shanghai) Ltd. and China Gateway Pharma Products (Chengdu) Ltd., ShangPharma offers global pharmaceutical, biotechnology and chemical companies comprehensive services and materials for their research and development needs. ShangPharma currently has a team of more than 1,800 professionals, and more than 60% of the employees have post graduate educational experience of Master or Ph.D. degrees. ShangPharma has established comprehensive R&D partnerships with world-class academic institutes, universities as well as healthcare industry and organizations, to contribute more added-value for its clients' success.

Further information is available at http://www.shangpharma.com .

About AAALAC International

AAALAC International is a private, non-profit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. AAALAC stands for the "Association for Assessment and Accreditation of Laboratory Animal Care."

More than 800 companies, universities, hospitals, government agencies and other research institutions in 32 countries have earned AAALAC accreditation, demonstrating their commitment to responsible animal care and use. These institutions volunteer to participate in AAALAC's program, in addition to complying with the local, state and federal laws that regulate animal research.

Further information is available at http://www.aaalac.org

SOURCE Shanghai ChemPartner

Back to top

RELATED LINKS
http://www.shangpharma.com
http://www.aaalac.org

'/>"/>

SOURCE Shanghai ChemPartner
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
2. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
3. Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference
4. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
5. Shanghai CRO Service Alliance Adds Clinical Development Capabilities
6. Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company
7. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
8. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
9. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
10. Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration
11. Sundia Shortens CRO Shipment Delivery Time with Express Customs Clearance in Shanghai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/27/2016)... , June 27, 2016 Research and ... North America 2016-2020" report to their offering. ... North America to grow at a CAGR of ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:6/22/2016)... 2016  The American College of Medical Genetics and Genomics ... as one of the fastest-growing trade shows during the ... Bellagio in Las Vegas . ... growth in each of the following categories: net square feet ... of attendees. The 2015 ACMG Annual Meeting was ranked 23 ...
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
Breaking Biology News(10 mins):